ad Detroit-Area Doctor Admits to Providing Medically Unnecessary Chemotherapy to Patients By www.justice.gov Published On :: Tue, 16 Sep 2014 16:36:59 EDT A Detroit-area hematologist-oncologist pleaded guilty today for his role in a health care fraud scheme, admitting that he administered unnecessary chemotherapy to fraudulently bill the Medicare program and private insurance companies. According to court records, the scheme enabled the doctor to submit approximately $225 million in claims to Medicare over six years. Full Article OPA Press Releases
ad Pennsylvania Man Pleads Guilty in Conspiracy to Illegally Export Restricted Laboratory Equipment to Syria By www.justice.gov Published On :: Wed, 17 Sep 2014 11:22:35 EDT U.S. Attorney Peter Smith for the Middle District of Pennsylvania, Special Agent in Charge John Kelleghan for Philadelphia, U.S. Immigration and Customs Enforcement’s (ICE) Homeland Security Investigations (HSI) and Special Agent in Charge Sidney M. Simon of the New York Field Office, Office of Export Enforcement, U.S. Department of Commerce announced that yesterday Harold Rinko, 72, of Hallstead, Pennsylvania, appeared before Senior District Court Judge Edwin M. Kosik in Scranton and pleaded guilty to conspiracy to illegally export laboratory equipment, including items used to detect chemical warfare agents, from the United States to Syria, in violation of federal law Full Article OPA Press Releases
ad Two Former Rabobank Traders Indicted for Alleged Manipulation of U.S. Dollar, Yen Libor Interest Rates By www.justice.gov Published On :: Thu, 23 Oct 2014 11:08:25 EDT Two former Coöperatieve Centrale Raiffeisen-Boerenleenbank B Full Article OPA Press Releases
ad Alabama Real Estate Investor Pleads Guilty to Conspiracy to Commit Mail Fraud By www.justice.gov Published On :: Mon, 3 Nov 2014 14:58:31 EST An Alabama real estate investor pleaded guilty yesterday for his role in a conspiracy to commit mail fraud related to public real estate foreclosure auctions held in southern Alabama, the Department of Justice announced today Full Article OPA Press Releases
ad Northern California Real Estate Investor Agrees to Plead Guilty to Bid Rigging and Fraud at Public Foreclosure Auctions By www.justice.gov Published On :: Wed, 3 Dec 2014 09:45:52 EST A Northern California real estate investor has agreed to plead guilty for his role in conspiracies to rig bids and commit mail fraud at public real estate foreclosure auctions in Northern California, the Department of Justice announced Full Article OPA Press Releases
ad Justice Department and State Partners Secure $1.375 Billion Settlement with S&P for Defrauding Investors in the Lead Up to the Financial Crisis By www.justice.gov Published On :: Tue, 3 Feb 2015 16:01:53 EST Attorney General Eric Holder announced today that the Department of Justice and 19 states and the District of Columbia have entered into a $1.375 billion settlement agreement with the rating agency Standard &s Financial Services LLC, along with its parent corporation McGraw Hill Financial Inc., to resolve allegations that S&s 2013 lawsuit against S& true credit risks. Other allegations assert that S&s business relationships with the investment banks that issued the securities. Full Article OPA Press Releases
ad Northern California Real Estate Investor Agrees to Plead Guilty to Bid Rigging and Fraud Conspiracies at Public Foreclosure Auctions By www.justice.gov Published On :: Thu, 9 Apr 2015 12:52:09 EDT A Northern California real estate investor has agreed to plead guilty for his role in bid rigging and fraud conspiracies at public real estate foreclosure auctions in Northern California, the Department of Justice announced Full Article OPA Press Releases
ad Deutsche Bank's London Subsidiary Agrees to Plead Guilty in Connection with Long-Running Manipulation of LIBOR By www.justice.gov Published On :: Fri, 24 Apr 2015 09:35:43 EDT DB Group Services (UK) Limited, a wholly owned subsidiary of Deutsche Bank AG (Deutsche Bank), has agreed to plead guilty to wire fraud for its role in manipulating the London Interbank Offered Rate (LIBOR), a leading benchmark interest rate used in financial products and transactions around the world Full Article OPA Press Releases
ad Former Owner of Empire Towers Pleads Guilty for Fraudulent $7 Million Bond Scheme and Filing False Tax Return By www.justice.gov Published On :: Thu, 28 May 2015 13:20:24 EDT Misled More Than 50 Individual Investors Who Bought Bonds A former Queenstown, Maryland, resident pleaded guilty today to securities fraud and filing a false tax return Full Article OPA Press Releases
ad Father Of Former Investment Bank Managing Director Pleads Guilty To Insider Trading Conspiracy By www.justice.gov Published On :: Wed, 12 Aug 2015 21:09:53 EDT Preet Bharara, the United States Attorney for the Southern District of New York, announced that ROBERT STEWART, the father of former investment bank managing director Sean Stewart, pled guilty today to participating in a conspiracy to trade on inside information about several mergers and acquisitions announced between 2011 and 2014 Full Article OPA Press Releases
ad Real Estate Investor Pleads Guilty to Bid Rigging and Fraud Conspiracies at Georgia Public Foreclosure Auctions By www.justice.gov Published On :: Wed, 7 Oct 2015 20:45:21 EDT A Georgia real estate investor pleaded guilty today for his role in conspiracies to rig bids and commit mail fraud at public real estate foreclosure auctions in Fulton and DeKalb counties, Georgia Full Article OPA Press Releases
ad Former California Attorney Pleads Guilty in International Investment Fraud Scheme By www.justice.gov Published On :: Wed, 25 Nov 2015 08:45:26 EST A Las Vegas man pleaded guilty today to conspiracy for his role in an investment fraud scheme that promoted fraudulent investment opportunities and caused more than $5 million in losses to investors Full Article OPA Press Releases
ad Justice Department Reaches $470 Million Joint State-Federal Settlement with HSBC to Address Mortgage Loan Origination, Servicing and Foreclosure Abuses By www.justice.gov Published On :: Wed, 17 Feb 2016 19:56:24 EST The Justice Department, the Department of Housing and Urban Development (HUD) and the Consumer Financial Protection Bureau, along with 49 state attorneys general and the District of Columbia’s attorney general, have reached a $470 million agreement with HSBC Bank USA NA and its affiliates (collectively, HSBC) to address mortgage origination, servicing and foreclosure abuses Full Article OPA Press Releases
ad Former Postal Clerk Pleads Guilty to Stealing Mail By www.justice.gov Published On :: Wed, 23 Mar 2016 20:45:27 EDT NORFOLK, Va Full Article OPA Press Releases
ad New York Man Pleads Guilty to Conspiracy to Defraud U.S. Defense Contractors By www.justice.gov Published On :: Tue, 29 Mar 2016 20:45:42 EDT ALEXANDRIA, Va Full Article OPA Press Releases
ad Former Fox News Commentator Pleads Guilty to Fraud By www.justice.gov Published On :: Mon, 2 May 2016 08:45:35 EDT ALEXANDRIA, Va Full Article OPA Press Releases
ad Alexandria Adult Day Healthcare Center Settles Civil Fraud Allegations By www.justice.gov Published On :: Wed, 4 May 2016 08:45:24 EDT ALEXANDRIA, Va Full Article OPA Press Releases
ad Former Director of General Services Administration Division and Husband Indicted for Fraud and Nepotism By www.justice.gov Published On :: Wed, 15 Jun 2016 14:45:25 EDT ALEXANDRIA, Va Full Article OPA Press Releases
ad Toano Man Pleads Guilty to Impersonating a Federal Agent By www.justice.gov Published On :: Fri, 24 Jun 2016 20:45:27 EDT NEWPORT NEWS, Va Full Article OPA Press Releases
ad Former Nurse Pleads Guilty to ID Theft and Bank Fraud By www.justice.gov Published On :: Fri, 24 Jun 2016 20:45:27 EDT RICHMOND, Va Full Article OPA Press Releases
ad What’s New Health Canada? November 2019 Updates By feedproxy.google.com Published On :: Fri, 20 Dec 2019 14:41:48 +0000 By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/update-miseajour/index-eng.php Medical Devices: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/what-new.html Natural and Non-prescription Health Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/what-new.html Updates from Health Canada Type of Update and Link Date Posted Notice – Update to Clinical Trial Site Information Form 29 November … Continue reading » Full Article Canadian Regulatory Affairs Cato Research Health Canada regulatory
ad New FDA Guidances for November and December 2019 and Upcoming Advisory Committee Meetings By feedproxy.google.com Published On :: Mon, 06 Jan 2020 21:36:51 +0000 By Alice Li, MD, MSc, RAC(CAN), Regulatory Scientist, Cato Research Special Interest Guidances/Information Date Posted Guidance for Industry: Serving Sizes of Foods That Can Reasonably Be Consumed At One Eating Occasion, Reference Amounts Customarily Consumed, Serving Size-Related Issues, Dual-Column Labeling, and Miscellaneous Topics – Final Guidance 30 Dec 2019 Submission of Plans for Cigarette Packages … Continue reading » Full Article FDA Regulatory Guidances FDA Guidances
ad New FDA Gudiances for January 2020 and Upcoming Advisory Committee Meetings By feedproxy.google.com Published On :: Tue, 04 Feb 2020 20:21:28 +0000 By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS Special Interest Guidances/Information Date Posted Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components; Draft Guidance for Industry: Draft Guidance for Industry – Draft Guidance 30 Jan 2020 Arthroscopy Pump Tubing Sets … Continue reading » Full Article FDA FDA Regulatory Guidances Rare Diseases Regulatory Affairs Cato Research FDA Guidances rare diseases
ad What’s New Health Canada? January and February 2020 Updates By feedproxy.google.com Published On :: Wed, 04 Mar 2020 17:52:44 +0000 By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/update-miseajour/index-eng.php Medical Devices: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/what-new.html Natural and Non-prescription Health Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/what-new.html Updates from Health Canada Type of Update and Link Date Posted Notice: Product Monograph Implementation Plans 13 January 2020 … Continue reading » Full Article Health Canada Updates Health Canada Regulatory Authorities
ad New FDA Gudiances for February 2020 and Upcoming Advisory Committee Meetings By feedproxy.google.com Published On :: Wed, 04 Mar 2020 18:28:34 +0000 By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS Special Interest Guidances/Information Date Posted Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency: Immediately in Effect Guidance for Clinical Laboratories and Food and … Continue reading » Full Article FDA Regulatory Guidances CATOSMS FDA FDA Guidances Regulatory Authorities
ad New FDA Gudiances for March 2020 and Upcoming Advisory Committee Meetings By feedproxy.google.com Published On :: Mon, 06 Apr 2020 20:00:27 +0000 By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Strategy, CATO SMS FDA guidances from March 2020 as well as upcoming advisory committee meeting announcements are below. We note that approximately one-third of FDA’s guidances this past month are related to COVID-19. Special Interest Guidances/Information Date Posted Enforcement Policy for Gowns, Other Apparel, and … Continue reading » Full Article FDA Regulatory Guidances Cato Research FDA FDA Guidances
ad Consideration for ongoing clinical trials: Ensuring Participant Safety and Adapting New Processes during COVID‑19 Pandemic By feedproxy.google.com Published On :: Wed, 29 Apr 2020 13:00:12 +0000 By Ashley Henderson, PhD, CATO SMS Scientist 1.0 INTRODUCTION The COVID‑19 pandemic has added an unprecedented set of challenges to the conduct of clinical trials including quarantines, travel limitations, site closures, and interruptions in the supply chain of investigational products. In acknowledgement of these challenges, the Food and Drug Administration (FDA) recognizes that protocol modifications … Continue reading » Full Article Clinical Trials CATOSMS COVID-19
ad New FDA Gudiances for April 2020 and Upcoming Advisory Committee Meetings By feedproxy.google.com Published On :: Fri, 01 May 2020 21:21:17 +0000 By Zachary Swan, PhD, RAC, Associate Director, Regulatory Affairs at CATO SMS Special Interest Guidances/Information Date Posted Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency: Guidance for Industry – Final Guidance 30 April 2020 FDA Deems Certain Tobacco Products Subject to FDA Authority, … Continue reading » Full Article FDA Regulatory Guidances CATO SMS FDA Guidances
ad What’s New Health Canada? By feedproxy.google.com Published On :: Thu, 07 May 2020 21:44:25 +0000 By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/update-miseajour/index-eng.php Medical Devices: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/what-new.html Natural and Non-prescription Health Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/what-new.html Updates from Health Canada New Private Label Medical Device Licence Application Form 07 April 2020 Guidance Document: How to Complete the … Continue reading » Full Article Canadian Regulatory Affairs Cato Research Health Canada CATOSMS
ad SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch By www.rttnews.com Published On :: Fri, 24 Apr 2020 05:43:19 GMT Today's Daily Dose brings you news about Cassava Sciences' research grant from the National Institutes of Health for developing Alzheimer's disease drug; Edwards Lifesciences' Q1 financial results; Enzo Biochem's launch of the next-generation COVID-19 test kits and Johnson & Johnson's deal with Emergent BioSolutions related to COVID-19 Vaccine candidate. Full Article
ad Axsome Therapeutics (AXSM) Advances To Cross $100-Mark By www.rttnews.com Published On :: Mon, 27 Apr 2020 10:45:29 GMT Axsome Therapeutics Inc.'s (AXSM) phase II/III trial of investigational drug AXS-05 in Alzheimer's disease agitation has met the primary endpoint. Full Article
ad Avadel (AVDL) Soars On REST-ON Trial Results By www.rttnews.com Published On :: Mon, 27 Apr 2020 12:11:18 GMT Avadel Pharmaceuticals plc's (AVDL) pivotal phase III trial evaluating FT218 for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy has met its three co-primary efficacy endpoints at all three doses. Full Article
ad Gilead's Remdesivir Becomes 1st Drug Allowed For Emergency Use For COVID-19 By www.rttnews.com Published On :: Sat, 02 May 2020 02:41:07 GMT The FDA has issued emergency use authorization for Gilead Science Inc's (GILD) antiviral drug Remdesivir for the treatment of COVID-19 in adults and children hospitalized with severe disease. Full Article
ad FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads By www.rttnews.com Published On :: Thu, 07 May 2020 03:33:38 GMT Today's Daily Dose brings you news about the revised FDA decision date for Bristol Myers' CAR T cell therapy for refractory large B-cell lymphoma; Enanta Pharma's primary biliary cholangitis trial results; MacroGenics' anticipated clinical data read-outs and regulatory event for this year and Trovagene's name change. Full Article
ad Relmada Therapeutics (RLMD): Sending The Right Signals? By www.rttnews.com Published On :: Tue, 28 Apr 2020 10:46:01 GMT Shares of Relmada Therapeutics Inc. (RLMD) have gained 19 percent so far this year and trade around $37. Full Article
ad HIAs and Other Resources to Advance Health-Informed Decisions By feedproxy.google.com Published On :: Sun, 29 Apr 2018 18:08:46 Z The Health Impact Project’s toolkit contains resources that help communities, agencies, and other organizations take action to improve public health. The toolkit offers a collection of health impact assessments, guides, and other research to support policymakers’ efforts to consider health when making decisions across sectors, such as housing, planning, and education. Full Article
ad Policy Priorities to Address Opioid Use Disorder By feedproxy.google.com Published On :: Thu, 23 Apr 2020 07:00:00 -0400 Individuals with opioid use disorder (OUD) struggle to get effective care: Of 2 million Americans with the illness, only 26% receive treatment. Now, as the coronavirus pandemic presents an added strain on the U.S. health care system, it is creating greater hardships for those seeking OUD treatment. Full Article
ad Pew Calls On DEA to Expedite Addiction Treatment Regulation By feedproxy.google.com Published On :: Mon, 27 Apr 2020 13:32:00 -0400 Pew’s substance use prevention and treatment initiative sent a letter to the Drug Enforcement Administration (DEA) on April 27 encouraging the agency to expedite a final rule that will help opioid treatment programs (OTPs)—federally regulated facilities where patients take medications for opioid use disorder under the supervision of medical staff and receive counseling and other care services—... Full Article
ad Some Indicators of Public Health in Philadelphia Had Improved Before COVID-19 By feedproxy.google.com Published On :: Tue, 28 Apr 2020 09:57:00 -0400 The spread of COVID-19 is placing unprecedented strain on Philadelphia’s hospitals, public health systems, and residents. Although the full effects of the emergency have yet to be realized, newly released data from 2018 and 2019 provides insight on the state of public health in the city before the pandemic. Full Article
ad Pew Urges Congress to Promote Patient Matching in Electronic Health Records to Address COVID-19 By feedproxy.google.com Published On :: Mon, 04 May 2020 13:32:47 -0400 The Pew Charitable Trusts sent a letter May 4 to the leaders of the Senate and House of Representatives urging them to support improved patient matching in electronic health records to help combat the COVID-19 pandemic. Full Article
ad Recipe For Managing Data Disclosure Successfully With Academic Partners: A Public Gene Therapy Company Perspective By feedproxy.google.com Published On :: Tue, 24 Mar 2020 11:17:45 +0000 This blog post was written by Deanna Petersen, CBO of AVROBIO, as part of the From The Trenches feature of LifeSciVC. When AVROBIO went public in June 2018, I found myself on the steep end of an unexpected but interesting The post Recipe For Managing Data Disclosure Successfully With Academic Partners: A Public Gene Therapy Company Perspective appeared first on LifeSciVC. Full Article Business Development From The Trenches academic partners clinical trials gene therapy
ad Ordinary People Achieving The Extraordinary: Lessons In Leadership From The Court To The C-suite By feedproxy.google.com Published On :: Thu, 30 Apr 2020 10:37:19 +0000 This blog was written by Josh Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC. I stood in front of 15 skeptical parents and prepared to sell them on an improbable mission. They had The post Ordinary People Achieving The Extraordinary: Lessons In Leadership From The Court To The C-suite appeared first on LifeSciVC. Full Article From The Trenches Leadership
ad Long-Range Planning (LRP): Reframed Leaders Require Purpose By feedproxy.google.com Published On :: Fri, 08 May 2020 11:35:00 +0000 This blog was written by Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC. In an environment where senior leaders are tasked with defining agile strategies in uncertain times, there are many perspectives The post Long-Range Planning (LRP): Reframed Leaders Require Purpose appeared first on LifeSciVC. Full Article Corporate Culture From The Trenches Leadership Leaders Require Purpose Long Range Planning LRP
ad Amin Talati Continues its Expansion in Washington DC With Addition Of Dietary Supplement Industry Leader By feedproxy.google.com Published On :: Mon, 05 Feb 2018 17:56:00 GMT Rend Al-Mondhiry has joined the firm Amin Talati from the Council for Responsible Nutrition (CRN) as Senior Counsel, resident in the Washington, D.C. Office. Full Article
ad 'Doctor' Tony Huge: Brand Ambassador or Founder/Boss of Enhanced Athlete? By feedproxy.google.com Published On :: Thu, 08 Feb 2018 20:02:00 GMT New Legal Motion Challenges Tony Huge’s Supposed Unpaid Role in Enhanced Athlete Full Article
ad Organic Trade Association and The Organic Center Applaud Senate Bill, Organic Agriculture Research By feedproxy.google.com Published On :: Thu, 08 Feb 2018 22:38:00 GMT The Organic Trade Association and The Organic Center on Thursday applauded Senators Bob Casey (D-PA) and Susan Collins (R-ME) for introducing The Organic Agriculture Research Act of 2018. Full Article
ad PR—The Most Important Part of Trade Show Marketing By feedproxy.google.com Published On :: Fri, 09 Feb 2018 19:07:00 GMT Natural product brands can boost trade show ROI by investing in PR to work with trade press via press releases and onsite interviews. Full Article
ad Ad Agency Settles FTC, Maine AG Complaint By feedproxy.google.com Published On :: Mon, 12 Feb 2018 20:23:00 GMT An advertising agency agreed to settle a complaint brought by state and federal regulators over the creation and dissemination of allegedly deceptive radio advertisements for weight-loss products. Full Article
ad Immunity products: "This is the world's biggest ever advertising campaign, bar none" By www.nutraingredients.com Published On :: Tue, 05 May 2020 10:30:00 +0100 It is "inconceivable" that immunity will not remain high on the list of health priorities when this pandemic ends and now is the time to create more "convincing experiences" to ensure trial turns into adoption, according to food and drink research and branding experts. Full Article Markets and Trends
ad The inside-out beauty boom? Nutricosmetics start-up D+ For Care says ‘the whole world is ready’ By www.cosmeticsdesign-europe.com Published On :: Thu, 07 May 2020 09:27:00 +0100 French beauty supplement firm D+ For Care has launched a mouth spray to aid sleep and has a flurry of holistic wellbeing innovation primed for 2020 â the year nutricosmetics could really take off, its founder says. Full Article Manufacturers
